Sweeney WE et al.Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.World J Nephrol 6:188-200 (2017).
Sui M et al.Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer.Exp Ther Med 14:657-663 (2017).
Zhang YS et al.Hybrid Microscopy: Enabling Inexpensive High-Performance Imaging through Combined Physical and Optical Magnifications.Sci Rep 6:22691 (2016).
Wang Z et al.The role of MAPK signaling pathway in the Her-2-positive meningiomas.Oncol Rep 36:685-95 (2016).
Sanabria-Figueroa E et al.Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.Mol Pharmacol 87:150-61 (2015).
Lai Q et al.Positive correlation between the expression of hEag1 and HIF-1a in breast cancers: an observational study.BMJ Open 4:e005049 (2014).
Stacpoole SR et al.Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantation.Stem Cells Transl Med 2:464-72 (2013).
Ward TM et al.Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5.Oncogene : (2012).
Hurtado A et al.Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.Nature 456:663-6 (2008).
Zhau HE et al.Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.Mol Carcinog 3:254-7 (1990).
Meissner K et al.Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.Am J Pathol 137:1305-9 (1990).
van de Vijver MJ et al.Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.N Engl J Med 319:1239-45 (1988).